According to Gurova et al., loss of apoptosis through p53 inactivation leads to genetic instability and tumor progression, whereas loss of apoptosis through bcl-2 overexpression creates genetically stable tumors that escape the selective pressure to inactivate p53 and are therefore less prone to progression, leading to a better prognostic outcome [68]. This evidence concerns the gene BCL2 and neoplasm.